Rigau V, Morin M, Rousset M-C, de Bock F, Lebrun A, Coubes P, Picot M-C, Baldy-Moulinier M, Bockaert J, Crespel A, et al
We are committed to this level of transparency, providing clean, science-forward formulations that you can trust
We'll also explore what research has revealed about this peptide bioregulator, while being clear about both the evidence and its limitations
Plasma advanced glycation end products are associated with incident cardiovascular events in individuals with type 2 diabetes: a case-cohort study with a median follow-up of 10 years (EPIC-NL)
This article synthesizes peer-reviewed research on GHK-Cus biological activity and its rapidly expanding applications in clinical aesthetics